Vitamin B12 (Methylcobalamin)Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 1 mg (1000 mcg) or higher sometimes
Reference Brands: Cyanokit(US)
Category:
Nutraceuticals
Vitamin B12 (Methylcobalamin) injections support nerve health, red blood cell production, and DNA synthesis by providing active coenzyme B12 directly into the bloodstream. They improve neurological function, treat deficiencies, and boost energy, helping manage anemia, neuropathy, and overall vitality in deficient patients worldwide.
Vitamin B12 (Methylcobalamin)injection is available in Injection
and strengths such as 1 mg (1000 mcg) or higher sometimes.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Vitamin B12 (Methylcobalamin)injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Vitamin B12 (Methylcobalamin)injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Vitamin B12 (Methylcobalamin) injection, marketed as methylcobalamin, is approved in the US by the FDA and in the EU via EMA for correcting severe deficiency states. Regulatory approval requires comprehensive dossiers covering clinical efficacy, safety data, manufacturing quality, and pharmacovigilance. The FDA reviews clinical trial data and manufacturing standards for timely approval, while the EMA ensures compliance with regional safety and quality regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports swift approval, safe administration, and worldwide availability, helping manage neurological and hematological deficiencies effectively across healthcare regions globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing